Today: 19 April 2026
GE Vernova stock price jumps 4% ahead of earnings as traders hunt for guidance
27 January 2026
2 mins read

GE Vernova stock price jumps 4% ahead of earnings as traders hunt for guidance

New York, January 27, 2026, 13:07 (EST) — Regular session

Shares of GE Vernova Inc. (NYSE: GEV) jumped about 4.1% to $693.27 by midday Tuesday, beating a jittery U.S. market ahead of earnings. The stock hit an intraday high of $694.63 after opening at $676.17, with volume around 2.2 million shares.

The news comes just a day before GE Vernova is set to report its Q4 and full-year 2025 results. The company will publish the numbers ahead of U.S. market open on Wednesday. CEO Scott Strazik and CFO Ken Parks are scheduled to break down the details in a webcast at 7:30 a.m. ET.

Why it matters now: GE Vernova’s shares have been creeping closer to recent highs amid rising anticipation for its earnings report. The stock closed Monday at $665.99, about $65 below its 52-week peak of $731 reached on Dec. 10, per MarketWatch data.

The broader market sent mixed signals. The S&P 500 crept up 0.22%, while the Nasdaq 100 rose 0.44% by midday. The Dow, in contrast, dropped 0.64%, data from Nasdaq.com showed.

Analysts at Zacks Equity Research forecast earnings per share hitting $3.03, up roughly 75% from last year, on revenues of $10.04 billion. Yet, sales are expected to fall about 5%. The firm pointed to softer outlooks in the wind segment, with revenue set to drop nearly 29% year over year. At the same time, electrification revenue is forecast to rise around 23%.

The bull case still leans on rising power demand from data centers, pushing up orders for grid gear and gas turbines. In December, GE Vernova forecasted revenue between $41 billion and $42 billion for 2026, with free cash flow expected to range from $4.5 billion to $5.0 billion. The company also expanded its share buyback program to $10 billion and doubled its quarterly dividend to 50 cents.

At its December investor day, William Blair analyst Jed Dorsheimer called the event “firing on all cylinders,” pointing to turbine production slots secured through 2028. GE Vernova said it expects to reach 80 gigawatts of signed combined-cycle gas turbine contracts by year-end and aims to boost gas-turbine output to about 20 GW by mid-2026. Competitors Siemens Energy and Mitsubishi Heavy Industries have also raised their targets. Reuters

Traders are zeroed in not just on whether GE Vernova beats earnings but on the stock’s reaction around earnings events. Benzinga data showed GE Vernova missed EPS estimates by $0.19 last quarter, yet its shares rose 3.32% the next day. This underscores how guidance often trumps the reported numbers.

Risks can surface quickly, especially when it comes to specialist material supply. In December, Strazik revealed the company’s collaboration with the U.S. government to boost yttrium stockpiles — a rare earth element vital for energy, aerospace, and semiconductors — following China’s tighter export controls. “We are very focused on it every day,” he said. Prices outside China soared about 4,400% from January to November 2025, highlighting how fast costs can jump. Reuters

Investors are bracing for the Jan. 28 update, keen to spot any shifts in 2026 outlooks, especially in power and electrification. They’ll also watch closely for clues that the wind segment’s troubles might be stabilizing. The guidance—and the mood on the earnings call—could steer the stock’s next move once trading resumes.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Texas Instruments stock price nudges up ahead of earnings as guidance comes into focus
Previous Story

Texas Instruments stock price nudges up ahead of earnings as guidance comes into focus

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom
Next Story

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom

Go toTop